Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Solid Tumors × adavosertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Uterine Cervical Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Advanced Malignant Solid Neoplasm 2 Vaginal Neoplasms 1 Triple-negative Metastatic Breast Cancer 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Rhabdomyosarcoma 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Pinealoma 1 Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Metastatic Pancreatic Adenocarcinoma 1 Meningeal Carcinomatosis 1 Medulloblastoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Gemcitabine 5 Paclitaxel 3 Nivolumab 3 cobimetinib 2 atezolizumab 2 Ramucirumab 2 Carboplatin 2 zansecimab 1 tocilizumab 1 tivozanib 1 tislelizumab 1 temsirolimus 1 ridaforolimus 1 plocabulin 1 pevonedistat 1 pembrolizumab 1 pamiparib 1 obinutuzumab 1 necitumumab 1 liposomal doxorubicin 1 lenvatinib 1 glasdegib 1 futuximab 1 demplatin pegraglumer 1 birinapant 1 adavosertib 1 Temozolomide 1 TAK-981 1 Sunitinib 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00648648 2023-09-21

MK-1775-001

Merck Sharp & Dohme LLC

Phase 1 Completed

206 enrolled 40 charts

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡